Classification of tumours of the central nervous system using nanopore sequencing

Nanopore technology provides the ability to evaluate single nucleotide variants, copy number variants (CNVs), and methylation patterns, in parallel, here demonstrated in the context of central nervous system (CNS) tumour marker analysis, with the potential to provide clinicians with actionable data to assist in diagnosis and guiding treatment, in future.

Download the poster to discover:

  • A nanopore adaptive sampling workflow for the parallel analysis of multiple CNS tumour markers, integrating variant and methylation-based classification
  • How off-target reads can be used for CNV and methylation profiling
  • How the information provided by such a workflow could potentially be used to guide clinical decision making in future

Download the PDF